127 related articles for article (PubMed ID: 23712276)
1. [Impact of operator experience on TURB of high-grade non-muscle-invasive bladder cancer--analysis of 254 second resections at a university teaching hospital].
Lazica DA; Degener S; Böttcher S; Brandt AS; Störkel S; Roth S
Aktuelle Urol; 2013 May; 44(3):196-200. PubMed ID: 23712276
[TBL] [Abstract][Full Text] [Related]
2. [T1 high-grade bladder cancer - value of second operation with prognostuic parameters of first operation: analysis of 167 cases].
Lazica DA; Böttcher S; Degener S; von Rundstedt FC; Brandt AS; Roth S; Störkel S; Mathers MJ
Aktuelle Urol; 2013 Mar; 44(2):124-8. PubMed ID: 23580383
[TBL] [Abstract][Full Text] [Related]
3. Good quality white-light transurethral resection of bladder tumours (GQ-WLTURBT) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non-muscle-invasive bladder cancer: validation across time and place and recommendation for benchmarking.
Mariappan P; Finney SM; Head E; Somani BK; Zachou A; Smith G; Mishriki SF; N'Dow J; Grigor KM;
BJU Int; 2012 Jun; 109(11):1666-73. PubMed ID: 22044434
[TBL] [Abstract][Full Text] [Related]
4. Second transurethral resection after Ta high-grade bladder tumor: a 4.5-year period at a single university center.
Lazica DA; Roth S; Brandt AS; Böttcher S; Mathers MJ; Ubrig B
Urol Int; 2014; 92(2):131-5. PubMed ID: 23988813
[TBL] [Abstract][Full Text] [Related]
5. Fluorescence-guided transurethral resection of bladder tumours reduces bladder tumour recurrence due to less residual tumour tissue in Ta/T1 patients: a randomized two-centre study.
Hermann GG; Mogensen K; Carlsson S; Marcussen N; Duun S
BJU Int; 2011 Oct; 108(8 Pt 2):E297-303. PubMed ID: 21414125
[TBL] [Abstract][Full Text] [Related]
6. The presence of detrusor muscle in the pathological specimen after transurethral resection of primary pT1 bladder tumors and its relationship to operator experience.
Rouprêt M; Yates DR; Varinot J; Phé V; Chartier-Kastler E; Bitker MO; Compérat E
Can J Urol; 2012 Oct; 19(5):6459-64. PubMed ID: 23040628
[TBL] [Abstract][Full Text] [Related]
7. [Analysis of Clinical, Histopathological and Follow-Up Data on Transurethral Resections of the Bladder Performed during One Year at a University Centre].
Otto W; Fritsche HM; Dirmeyer M; Burger M; Straub M; Rössler W; Wieland WF; Denzinger S
Aktuelle Urol; 2010 Sep; 41(5):316-9. PubMed ID: 20669097
[TBL] [Abstract][Full Text] [Related]
8. Impact of surgical experience on recurrence and progression after transurethral resection of bladder tumour in non-muscle-invasive bladder cancer.
Jancke G; Rosell J; Jahnson S
Scand J Urol; 2014 Jun; 48(3):276-83. PubMed ID: 24286506
[TBL] [Abstract][Full Text] [Related]
9. Reducing recurrence in non-muscle-invasive bladder cancer by systematically implementing guideline-based recommendations: effect of a prospective intervention in primary bladder cancer patients.
Sörenby A; Baseckas G; Bendahl PO; Brändstedt J; Håkansson U; Nilsson S; Patschan O; Tinzl M; Wokander M; Liedberg F; Gudjonsson S
Scand J Urol; 2019; 53(2-3):109-115. PubMed ID: 31064253
[No Abstract] [Full Text] [Related]
10. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial.
Divrik RT; Yildirim U; Zorlu F; Ozen H
J Urol; 2006 May; 175(5):1641-4. PubMed ID: 16600720
[TBL] [Abstract][Full Text] [Related]
11. Presence of detrusor muscle in bladder tumor specimens--predictors and effect on outcome as a measure of resection quality.
Shoshany O; Mano R; Margel D; Baniel J; Yossepowitch O
Urol Oncol; 2014 Jan; 32(1):40.e17-22. PubMed ID: 23911682
[TBL] [Abstract][Full Text] [Related]
12. Assessment of diagnostic gain with hexaminolevulinate (HAL) in the setting of newly diagnosed non-muscle-invasive bladder cancer with positive results on urine cytology.
Neuzillet Y; Methorst C; Schneider M; Lebret T; Rouanne M; Radulescu C; Molinie V; Dreyfus JF; Pelcat V; Botto H
Urol Oncol; 2014 Nov; 32(8):1135-40. PubMed ID: 25023786
[TBL] [Abstract][Full Text] [Related]
13. Evaluating the efficacy of secondary transurethral resection of the bladder for high-grade Ta tumors.
Lee K; Jeong SH; Yoo SH; Ku JH
Investig Clin Urol; 2022 Jan; 63(1):14-20. PubMed ID: 34983118
[TBL] [Abstract][Full Text] [Related]
14. Fluorescence-guided transurethral resection of bladder cancer using hexaminolevulinate: analysis of health economic impact in Sweden.
Malmström PU; Hedelin H; Thomas YK; Thompson GJ; Durrant H; Furniss J
Scand J Urol Nephrol; 2009; 43(3):192-8. PubMed ID: 19330681
[TBL] [Abstract][Full Text] [Related]
15. Repeat transurethral resection for non-muscle-invasive bladder cancer: a contemporary series.
Gendy R; Delprado W; Brenner P; Brooks A; Coombes G; Cozzi P; Nash P; Patel MI
BJU Int; 2016 Apr; 117 Suppl 4():54-9. PubMed ID: 26486968
[TBL] [Abstract][Full Text] [Related]
16. Grading and staging of bladder carcinoma in transurethral resection specimens. Correlation with 105 matched cystectomy specimens.
Cheng L; Neumann RM; Weaver AL; Cheville JC; Leibovich BC; Ramnani DM; Scherer BG; Nehra A; Zincke H; Bostwick DG
Am J Clin Pathol; 2000 Feb; 113(2):275-9. PubMed ID: 10664630
[TBL] [Abstract][Full Text] [Related]
17. [Transurethral resection of bladder tumors: management of complications].
Rausch S; Gakis G; Stenzl A
Urologe A; 2014 May; 53(5):695-8. PubMed ID: 24806801
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance in substaging ofT1 urinary bladder urothelial carcinoma on transurethral resection.
Chang WC; Chang YH; Pan CC
Am J Surg Pathol; 2012 Mar; 36(3):454-61. PubMed ID: 22261706
[TBL] [Abstract][Full Text] [Related]
19. Ta T1 low and intermediate transitional cell carcinoma of the bladder: recurrence rates and the timing of check cystoscopies within the first year.
Guney S; Guney N; Canogullari Z; Ergenekon E
Urol Int; 2008; 80(2):124-8. PubMed ID: 18362479
[TBL] [Abstract][Full Text] [Related]
20. Outcome of very large superficial bladder tumours: a 10-year experience.
Gupta SK; Parr NJ
Scand J Urol Nephrol; 2008; 42(3):243-8. PubMed ID: 18432531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
